... preparation, narcosis or danger to the patient. Moreover, it allows a control of, and gives preliminary information on the success of,hormone or radiotherapy. Eur. Urol. 1: 189-192 (1975) The Effectiveness of Transrectal Aspiration Cytology in the Diagnosis of Prostatic Cancer R. Sonnenschein Urological...

...J.A. Martinez-Piñerio; P. Muntanola; L. Hidalog The immunological competence of 100 patients bearing urological cancers was evaluated by means of skin tests and serum immunoelectrophoresis. Cell-mediated immunodépressions were observed in 93.3% of prostatic cancers, 68.6% of bladder cancers...

... and 83% if it was 35 ng/1. These results indicate that a majority of European urologists would attempt to diagnose prostatic cancer with biopsies only when results of DRE and PSA predict a high risk that the cancer is no longer organ-confined. 11 8 2017 Prostatic cancer Early detection...

...Michael V. Hansen; Anders Grönberg The attitudes of 656 European urologists toward therapy of localized prostatic cancer (PC) and screening examinations of the male population for PC were surveyed. Eighty percent of the urologists would offer curative therapy to a 60-year-old patient with localized...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostatic cancer Clinical stage Histological grade Perineural infiltration Lymphatic infiltration Nuclear morphometry...

... on an association of PIN and invasive prostatic cancer have a follow-up of less than 1 year, indicating that the successively diagnosed cancer most probably was present at the time of diagnosis of PIN. The natural history of PIN is unknown and detection of PIN should therefore not influence therapeutic decisions...

...Claudio Giberti; Tommaso Barreca; Giuseppe Martorana; Mauro Truini; Roberto Francheschini; Ermanno Rolandi; Luciano Giuliani Seven patients suffering from prostatic cancer were treated with a depot form of D-Trp-6-luteinizing hormone-releasing hormone (LH-RH), a LH-RH agonist analogue (3 mg i.m...

... prostatic cancer. 26 men were referred to the Urology Service of the Aust-Agder Central Hospital for repeat examinations and further diagnostic procedures. Biopsies were performed on 16 patients, and transrectal ultrasound examination on 9. One patient was found to have prostate cancer. The value...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostatic cancer Radical prostatectomy Rectal injury European Urology Clinical Paper Eur Urol 1996;29:337-340 1605765 M. Häggmana S. Bmndstedt...

...G. Zanetti; A. Trinchieri; A. Del Nero; E. Montanari; M. Cogni; F. Colombo; V. Buzzetti; E. Austoni We have studied the prognostic significance of prostate-specific antigen (PSA), monitored monthly, in 24 patients with prostatic cancer (5 D1, 19 D2) on endocrine therapy. The pretreatment levels...

...J. Aro; R. Haapiainen; T. Sane; S. Rannikko; R. Pelkonen; O. Alfthan In 17 prostatic cancer patients, changes in the plasma lipoprotein pattern, including high density lipoprotein(HDL) subfractions, and in glucose tolerance were compared after 6 months on parenteral polyestradiol phosphate (PEP...

...A. Lewenhaupt; P. Ekman; P. Eneroth; A. Eriksson; B. Nilsson; L. Nordström In 93 patients suffering from prostatic cancer, serum levels of neopterin, a pteridine reflecting activation of the immune defence system, were measured at the time of diagnosis and 6 and 12 months after treatment...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostatic cancer Luteinizing hormone-releasing hormone analogue...

...J. W. Hetherington; J.K. Siddall; E.H. Cooper Changes in the serial measurements of serum prostatic acid phosphatase (PAP), and prostatic specific antigen (PSA) have been compared against changes in serial bone scans in 120 patients with prostatic cancer. Of 54 patients who presented with negative...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostatic cancer Methotrexate Pelvic malignancies Eur Urol 1990; 18...

... C. Servadio3, Z. Leib3, A. Levb Department of Urology, Beilinson Medical Center, Petah Tiqva, Tel Aviv University, Sackler School of Medicine, and b Department of Electronics, Weizmann Institute of Science, Rehovot, Israel 1607132 Key Words. Hyperthermia Prostatic cancer Benign hyperplasia...

...I. Romics; L. Lengyel The serum and urine hydroxyproline levels of patients with prostatic cancer were regularly studied for 30 months. Bone metastases were found in 4 patients at the beginning of the study; metastases formed in 8 patients during the test period, and in 9 patients no metastases...

... progression in about 60%, while poor regression grading was followed in about 50% by a satisfactory course. Fine-needle aspiration biopsy and grading of cytological regression is useful for follow-up of prostatic cancer after irradiation therapy. After hormone treatment, the grade of cytological regression...

...C.P. Henny; H. ten Cate; N.F. Dabhoiwala; H.R. Büller; J.W. ten Cate In three groups of patients with advanced prostatic cancer the influence of three different forms of hormonal manipulation, i.e. estrogens, anti-androgens and bilateral orchidectomy, on the coagulation and fibrinolytic systems has...

... excellent subjective responses to MPA treatment, lasting for several months. The reason for this transient flare reaction is poorly understood but most probably represents a temporary androgenic effect of high-dose MPA on the prostatic cancer cell. The clinician should be aware of the possibility...